Wall Street Zen downgraded shares of Afya (NASDAQ:AFYA – Free Report) from a buy rating to a hold rating in a research note released on Saturday morning.
Separately, UBS Group restated a “neutral” rating and issued a $19.50 price target (up previously from $17.50) on shares of Afya in a research note on Thursday, June 12th. Three investment analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to MarketBeat.com, Afya has an average rating of “Hold” and an average target price of $17.60.
Read Our Latest Stock Report on Afya
Afya Stock Down 4.4%
Institutional Trading of Afya
Institutional investors have recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio increased its stake in Afya by 40.0% during the fourth quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company’s stock valued at $44,000 after purchasing an additional 800 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in Afya by 1,099.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company’s stock valued at $64,000 after purchasing an additional 3,695 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Afya by 2,115.9% during the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company’s stock valued at $106,000 after purchasing an additional 6,369 shares during the last quarter. Aquatic Capital Management LLC increased its stake in Afya by 47.6% during the fourth quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company’s stock valued at $148,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Nuveen LLC bought a new stake in Afya during the first quarter valued at $226,000. Institutional investors own 88.02% of the company’s stock.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also
- Five stocks we like better than Afya
- What is the Nikkei 225 index?
- Why the American Eagle Stock Rally Isn’t Just Speculation
- Quiet Period Expirations Explained
- D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?
- 3 Fintech Stocks With Good 2021 Prospects
- 4 Stocks Planning to Substantially Boost Buybacks After Solid Q2
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.